Novartis has filed a lawsuit to block a Maryland law that requires them to supply medicines to any pharmacy working with hospitals in the 340B government drug discount program. The company argues that the law is illegal, preempted by federal law, and violates the U.S. Constitution. The 340B program was created to help hospitals and clinics care for low-income and rural patients by requiring drug companies to offer discounted medicines to participating healthcare facilities. This lawsuit is part of a larger battle over the 340B program, with Novartis pushing back against the requirement to supply medicines to contract pharmacies.
Source link
Novartis sues Maryland over contract pharmacies in drug discount program
